"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
Recruiting
Phase 2
Interventional Study
Mycoplasma Genitalium
Non-gonococcal Urethritis (NGU)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- University of Washington · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective is to estimate the efficacy of tinidazole for the treatment of Mycoplasma genitalium (MG) among male patients who have been diagnosed with non-gonococcal urethritis (NGU) at the Public Health - Seattle \&King County (PHSKC) Sexual Health Clinic (SHC). Tinidazole was approved by the Food and Drug Administration (FDA) in May 2004 to treat other infections (i.e., trichomoniasis, giardia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥18 years of age
* Clinical diagnosis of NGU
* Urogenital MG documented by a positive NAAT in the prior 7 days
* Fluent in English
* Assigned male at birth
* Attending the PHSKC SHC
* Able to provide informed consent
* Able to undergo a test of cure (TOC) 21 days after complet…
Contacts